Clinical Trial Update: A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating long-term safety, tolerability, and effectiveness of olesoxime in patients with spinal muscular atrophy has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Olesoxime (TRO19622)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Muscular Atrophy, Spinal | Phase 2 | Status: COMPLETED | Results posted: 2019-08-09